Seasonal Allergies: Which Medication is Right for You?
Video courtesy of the FDA.
The prevalence of atopic dermatitis is 7.3% among US adults, and patients with atopic dermatitis and more severe disease have worse quality of life.
Vital wheat gluten oral immunotherapy induces desensitization in about half of patients with wheat allergy after a year of treatment.
Viaskin Peanut, an epicutaneous immunotherapy (EPIT), delivers small amounts of peanut protein through a wearable patch to induce desensitization.